News
Swedish biotech Hansa Biopharma (Nasdaq Stockholm: HNSA) has appointed Maria Törnsén as chief operating officer and president ...
Denmark’s Novo Nordisk has presented data at the European Congress of Obesity (ECO) showing that Wegovy (semaglutide ...
Swedish contract development and manufacturing firm Recipharm and France-based regulatory specialist ProductLife Group (PLG) ...
Hungary’s largest drugmaker Gedeon Richter (RICHT: HB) has announced its financial results for the first quarter of 2025, ...
US biotech Genentech and its parent, Swiss pharma giant Roche (ROG: SIX), have announced plans to invest more than $700 ...
US pharma stocks regained ground Monday after Donald Trump signed an executive order aiming to slash prescription drug prices ...
German life sciences company Bayer presented its first-quarter financial results and latest guidance for 2025 on Tuesday.
Swiss pharma giant Roche (ROG: SIX), the Breast International Group (BIG), Institut Jules Bordet Clinical Trials Support Unit ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Adzynma (apadamtase alfa/cinaxadamtase alfa; ...
Chinese biotech Minghui Pharmaceutical has sold certain rights to its experimental cancer drug MHB088C to Qilu Pharmaceutical ...
Swiss pharma giant Roche is investing $280 million to build a new biopharma manufacturing facility in Shanghai, as it doubles ...
Spanish dermatology specialist Almirall was the envy of investors on Monday, with its share price closing 10% higher.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results